Global Intravenous Solutions (Colloids) Market Research Report 2024

Publication ID:

PB502243233

Publication Date:

February 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
The global Intravenous Solutions (Colloids) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions (Colloids), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions (Colloids).
Report Scope
The Intravenous Solutions (Colloids) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Solutions (Colloids) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions (Colloids) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospital and Clinics
Ambulatory
Home Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Solutions (Colloids) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Intravenous Solutions (Colloids) Market Overview
1.1 Product Overview and Scope of Intravenous Solutions (Colloids)
1.2 Intravenous Solutions (Colloids) Segment by Type
1.2.1 Global Intravenous Solutions (Colloids) Market Value Comparison by Type (2024-2030)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Solutions (Colloids) Segment by Application
1.3.1 Global Intravenous Solutions (Colloids) Market Value by Application: (2024-2030)
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Solutions (Colloids) Revenue 2019-2030
1.4.2 Global Intravenous Solutions (Colloids) Sales 2019-2030
1.4.3 Global Intravenous Solutions (Colloids) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous Solutions (Colloids) Market Competition by Manufacturers
2.1 Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous Solutions (Colloids) Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous Solutions (Colloids) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Solutions (Colloids), Product Type & Application
2.7 Intravenous Solutions (Colloids) Market Competitive Situation and Trends
2.7.1 Intravenous Solutions (Colloids) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Solutions (Colloids) Players Market Share by Revenue
2.7.3 Global Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Solutions (Colloids) Retrospective Market Scenario by Region
3.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous Solutions (Colloids) Global Intravenous Solutions (Colloids) Sales by Region: 2019-2030
3.2.1 Global Intravenous Solutions (Colloids) Sales by Region: 2019-2024
3.2.2 Global Intravenous Solutions (Colloids) Sales by Region: 2025-2030
3.3 Global Intravenous Solutions (Colloids) Global Intravenous Solutions (Colloids) Revenue by Region: 2019-2030
3.3.1 Global Intravenous Solutions (Colloids) Revenue by Region: 2019-2024
3.3.2 Global Intravenous Solutions (Colloids) Revenue by Region: 2025-2030
3.4 North America Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.4.1 North America Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous Solutions (Colloids) Sales by Country (2019-2030)
3.4.3 North America Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.5.1 Europe Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous Solutions (Colloids) Sales by Country (2019-2030)
3.5.3 Europe Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous Solutions (Colloids) Sales by Country (2019-2030)
3.7.3 Latin America Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous Solutions (Colloids) Sales by Type (2019-2030)
4.1.1 Global Intravenous Solutions (Colloids) Sales by Type (2019-2024)
4.1.2 Global Intravenous Solutions (Colloids) Sales by Type (2025-2030)
4.1.3 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
4.2.1 Global Intravenous Solutions (Colloids) Revenue by Type (2019-2024)
4.2.2 Global Intravenous Solutions (Colloids) Revenue by Type (2025-2030)
4.2.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Solutions (Colloids) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous Solutions (Colloids) Sales by Application (2019-2030)
5.1.1 Global Intravenous Solutions (Colloids) Sales by Application (2019-2024)
5.1.2 Global Intravenous Solutions (Colloids) Sales by Application (2025-2030)
5.1.3 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
5.2.1 Global Intravenous Solutions (Colloids) Revenue by Application (2019-2024)
5.2.2 Global Intravenous Solutions (Colloids) Revenue by Application (2025-2030)
5.2.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Solutions (Colloids) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ICU Medical Inc.
6.1.1 ICU Medical Inc. Corporation Information
6.1.2 ICU Medical Inc. Description and Business Overview
6.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
6.1.5 ICU Medical Inc. Recent Developments/Updates
6.2 B. Braun Melsungen AG
6.2.1 B. Braun Melsungen AG Corporation Information
6.2.2 B. Braun Melsungen AG Description and Business Overview
6.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
6.2.5 B. Braun Melsungen AG Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Corporation Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Amanta Healthcare
6.5.1 Amanta Healthcare Corporation Information
6.5.2 Amanta Healthcare Description and Business Overview
6.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
6.5.5 Amanta Healthcare Recent Developments/Updates
6.6 Terumo Medical Corporation
6.6.1 Terumo Medical Corporation Corporation Information
6.6.2 Terumo Medical Corporation Description and Business Overview
6.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
6.6.5 Terumo Medical Corporation Recent Developments/Updates
6.7 Grifols S.A.
6.6.1 Grifols S.A. Corporation Information
6.6.2 Grifols S.A. Description and Business Overview
6.6.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
6.7.5 Grifols S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Solutions (Colloids) Industry Chain Analysis
7.2 Intravenous Solutions (Colloids) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Solutions (Colloids) Production Mode & Process
7.4 Intravenous Solutions (Colloids) Sales and Marketing
7.4.1 Intravenous Solutions (Colloids) Sales Channels
7.4.2 Intravenous Solutions (Colloids) Distributors
7.5 Intravenous Solutions (Colloids) Customers
8 Intravenous Solutions (Colloids) Market Dynamics
8.1 Intravenous Solutions (Colloids) Industry Trends
8.2 Intravenous Solutions (Colloids) Market Drivers
8.3 Intravenous Solutions (Colloids) Market Challenges
8.4 Intravenous Solutions (Colloids) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂